Trigulin 2 Tablet SR contains a combination of Glimepiride 2mg, Metformin 500mg and Pioglitazone 15mg in sustained-release tablet form. It belongs to the ANTI DIABETIC category and is manufactured and marketed by Glenmark Pharmaceuticals Ltd.
Composition
- Glimepiride: 2mg
- Metformin: 500mg
- Pioglitazone: 15mg
Product Information
- Product Name: Trigulin 2 Tablet SR
- Generic: Glimepiride 2mg + Metformin 500mg + Pioglitazone 15mg
- Dosage Form: Sustained-Release Tablet
- Manufacturer: Glenmark Pharmaceuticals Ltd
- Marketer: Glenmark Pharmaceuticals Ltd
- Category: ANTI DIABETIC
About Glimepiride, Metformin and Pioglitazone
Glimepiride is a sulfonylurea antidiabetic medicine that helps lower blood glucose by stimulating the pancreas to release insulin.
Metformin is an oral antidiabetic medicine that helps reduce blood glucose levels, primarily by decreasing glucose production in the liver and improving insulin sensitivity.
Pioglitazone is a thiazolidinedione antidiabetic medicine that improves insulin sensitivity and helps the body use insulin more effectively.
Usage Information
Use Trigulin 2 Tablet SR only as directed by your doctor or healthcare professional. Swallow the sustained-release tablet as instructed and follow the prescribed dosage and schedule.
For complete product information, including dosage, storage instructions, precautions, contraindications, and expiry details, refer to the original packaging before use.
